Inventor · disambiguated record
Francois-Rene Alexandre
Also filed as: ALEXANDRE FRANCOIS-RENE · ALEXANDRE FRANÇOIS-RENÉ
23 granted patents·8 pending applications·285 citations·filing 2005–2021
95Inventor score
Files withIDENIX PHARMACEUTICALS INC16IDENIX PHARMACEUTICALS LLC3MERCK SHARP & DOHME3PARSY CHRISTOPHE CLAUDE3BOGEN STEPHANE2
Top patents by PatentIndex Score
31 records- 0196US9309275B23′-deoxy nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·28 cites·24 claims
- 0296US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 0395US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 0494US9296778B23′,5′-cyclic phosphate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·37 cites·21 claims
- 0590US7534809B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2005·Granted May 19, 2009·16 cites·82 claims
- 0688US9353100B2Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infectionsPARSY CHRISTOPHE CLAUDE·Filed 2012·Granted May 31, 2016·8 cites·37 claims
- 0788US8481748B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 9, 2013·4 cites·42 claims
- 0887US8377962B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·14 cites·93 claims
- 0986US8309737B2Phosphinate ruthenium complexesPARSY CHRISTOPHE CLAUDE·Filed 2010·Granted Nov 13, 2012·4 cites·38 claims
- 1084US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 1184US8993595B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 31, 2015·8 cites·96 claims
- 1283US8765966B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·2 cites·42 claims
- 1382US9284307B2Macrocyclic serine protease inhibitorsPARSY CHRISTOPHE CLAUDE·Filed 2010·Granted Mar 15, 2016·8 cites·18 claims
- 1482US8003659B2Macrocyclic serine protease inhibitorsINDENIX PHARMACEUTICALS INC·Filed 2009·Granted Aug 23, 2011·10 cites·189 claims
- 1580US10202411B23′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Feb 12, 2019·3 cites·29 claims
- 1679US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 1778US10899788B2Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Granted Jan 26, 2021·3 cites·17 claims
- 1876US8410313B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Apr 2, 2013·1 cites·20 claims
- 1976US8044091B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·2 cites·25 claims
- 2068US9115095B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·0 cites·17 claims
- 2164US2022040214A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2256US10513534B22′-chloro nucleoside analogs for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Dec 24, 2019·0 cites·60 claims
- 2352US11040975B2Carbocyclic nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Jun 22, 2021·0 cites·8 claims
- 2452US2009047244A1Macrocyclic serine protease inhibitors iIDENIX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2550US8486991B2Enantiomerically pure phosphoindoles as HIV inhibitorsSTORER RICHARD·Filed 2011·Granted Jul 16, 2013·0 cites·22 claims
- 2647US2020179428A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Application pending·0 cites
- 2747US2016002281A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2845US2019185508A1Deuterated nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 2942US2016083413A12'-chloro nucleoside analogs for hcv infectionIDENIX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3038US2012252721A1Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitorDOUSSON CYRIL B·Filed 2012·Application pending·0 cites
- 3131US2017101431A1Nucleoside derivatives for the treatment of cancerDOUSSON CYRIL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francois-Rene Alexandre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →